NEW YORK, Aug. 4, 2016 /PRNewswire/ -- Alcentra Capital Corporation ABDC ("Alcentra" or the "Company"), a provider of customized debt and equity financing solutions primarily to lower middle-market companies based in the United States, today announced its financial results for the second quarter ended June 30, 2016.
Second Quarter 2016 Financial Highlights
- Total investment income of $10.6 million
- Net investment income of $5.9 million, or $0.44 per share
- Net increase in net assets resulting from operations of $1.4 million, or $0.10 per share
- Invested $39.3 million in debt and equity securities, including investments in 4 new portfolio companies
- Received proceeds from repayments and amortizations of $26.5 million
- Paid regular quarterly dividend of $0.34 per share on July 7, 2016
- Net asset value (NAV) of $191.1 million, or $14.16 per share, as of June 30, 2016
- Weighted Average Portfolio Leverage – 3.88x, which is a slight increase from the prior quarter of 3.72x
- Weighted Average Portfolio Yield – 11.7%, down from 12.0% in the prior quarter
Management Commentary
"We had another good quarter with net investment income exceeding 40 cents per share for two consecutive quarters.
Originations in the second quarter improved from the first quarter consistent with an improved M&A climate for lower middle market companies. We closed four new deals in the quarter representing $34.75 million of invested capital, thus representing a moderate increase in assets under management for the quarter. We continue to see attractive opportunities to deploy capital in growth companies across a variety of industry sectors.
Two significant events occurred within the last four weeks that will help us achieve our strategic objectives, which have been to reduce the level of PIK interest and equity in the portfolio.
The sale of City Carting to Tunnel Hill Partners has allowed us to consolidate City Carting into a much larger waste management platform with a deeper management team and broader geographic focus. The transaction also reduces the level of PIK income in the portfolio.
On August 1, 2016, our notes and warrants in DBI Holdings were repaid including the Holding Company PIK Note. We realized a gain on our warrant of $9.7 million.
The sale of City Carting and repayment of our loan to DBI has eliminated the two largest components of PIK income in the portfolio. It also reduces the equity exposure in our portfolio, and positions us favorably to redeploy that capital into new debt investments. We would expect this portfolio dynamic to continue for the next several quarters, allowing continued growth in net investment income.
Lastly, we continued to repurchase common stock over the last few weeks and will continue to do so selectively under our existing program as market conditions dictate."
Second Quarter 2016 Financial Results
For the three months ended June 30, 2016, total investment income was $10.6 million. This is an increase from the same period in the prior year mainly due to an increase of investments in the portfolio as well as fees associated with repayments. Interest and PIK income comprised $8.1 million and other income comprised $2.5 million, including $2.1 million of prepayment fees and $0.3 million of amendment fee income.
For the three months ended June 30, 2016, total expenses were $4.7 million. Interest and financing expenses for the three months ended June 30, 2016 was $1.6 million and the base management fee was $1.3 million. The income based incentive fee for the three months ended June 30, 2016 was $0.93 million and there was no capital gains incentive fee accrual. Professional fees and other general and administrative expenses totaled $0.91 million for the three months ended June 30, 2016.
Net investment income for the three months ended June 30, 2016 was $5.9 million ($0.44 per share).
During the three months ended June 30, 2016, we recorded a net realized gain on investments of $1.7 million and a net change in unrealized depreciation on investments of $5.9 million.
The net increase in net assets resulting from operations during the three months June 30, 2016, was $1.4 million, or $0.10 per share.
Per share results for the second quarter ended June 30, 2016 are based on average shares outstanding of 13.50 million.
Portfolio and Investment Activities
As of June 30, 2016, Alcentra had debt and equity investments in 33 portfolio companies with a total fair market value of $293.6 million. The average portfolio investment on a cost basis was $9.0 million and equity constituted 16.9% of the portfolio, down from 29% at the time of the IPO. During the second quarter ended June 30, 2016, Alcentra made investments of $39.3 million, including investments in 4 new portfolio companies and add on financing, and received proceeds from repayments and amortizations of investments of $26.5 million. As of June 30, 2016, the weighted average yield on debt investments was 11.7%, which was a slight decrease in the weighted average yield from the March 31, 2016 reporting period of 12.0%.
Second quarter 2016 investment activity included the following new portfolio company investments:
- Healthcare Associates of Texas, LLC ("HCAT") is a full-service physician practice group providing primary care and multi-specialty care via three locations in the Dallas-Fort Worth metro area. Alcentra invested $8.50 million in Second Lien Notes and $1.30 million in a delayed draw on April 30, 2016.
- Metal Powder Products ("MPP") is a leading manufacturer of ferrous and aluminum powder metal components for use in the automotive, lawn and garden, and light industrial sectors. Alcentra invested $8.25 million in subordinated notes and $0.50 million of equity on May 5, 2016.
- QRC Technologies designs, develops and services a host of proprietary Radio Frequency products and provides comprehensive integrated solutions primarily for government, military and law enforcement agencies. Alcentra invested $10 million in subordinated notes on May 20, 2016.
- Vectra (Duke Finance, LLC) is a technology-driven industrial company which operates through Magnetic Technology, Battery Technologies and Specialty Chemicals. Alcentra invested $7.5 million in Second Lien Notes on May 18, 2016.
Alcentra had no investments on non-accrual status as of June 30, 2016.
Liquidity and Capital Resources
At June 30, 2016, Alcentra had $5.0 million in cash and cash equivalents. Alcentra had $51.7 million of borrowings outstanding on its $135 million senior secured revolving credit facility and $51.5 million outstanding of Alcentra Capital InterNotes as of June 30, 2016.
Subsequent Events
- On July 20, 2016, Alcentra funded a $13,000,000 13.0% cash/3.0% PIK subordinated debt investment in Limbach Facility Services,LLC.
- On August 1, 2016, DBI Holdings, LLC repaid our senior subordinated notes ($9.6 million), senior PIK notes ($9.2 million), and warrants ($9.7 million) for total proceeds of $28.5 million
Third Quarter 2016 Dividend of $0.34 Per Share Declared
On August 4, 2016, the Company's Board of Directors declared a regular quarterly dividend of $0.34 per share for the third quarter of 2016 payable on October 6, 2016 to stockholders of record as of September 30, 2016.
Alcentra has adopted a dividend reinvestment plan ("DRIP") that provides for reinvestment of dividends on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, when the Company declares a cash dividend, stockholders who have not "opted out" of the DRIP at least three days prior to the dividend payment date will have their cash dividends automatically reinvested in additional shares of the Company's common stock. Those stockholders whose shares are held by a broker or other financial intermediary may receive dividends in cash by notifying their broker or other financial intermediary of their election.
Second Quarter 2016 Financial Results Conference Call
Management will host a conference call to discuss the operating and financial results at 10:00 am ET on Friday, August 5, 2016. To participate in the conference call, please dial (844) 832-0218 approximately 10 minutes prior to the call. International callers should dial (484) 756-4314. Please reference conference ID # 59795061.
A live webcast of the conference call will be available at http://investors.alcentracapital.com/events-presentations. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software.
An archived webcast replay will be available on the Company's website until August 5, 2017.
ABOUT ALCENTRA CAPITAL CORPORATION
Alcentra Capital Corporation provides customized debt and equity financing solutions to lower middle-market companies, which the Company generally defines as U.S. based companies having revenues between $10.0 million and $100.0 million. Alcentra' investment objective is to provide attractive risk-adjusted returns by generating both current income from our debt investments and capital appreciation from our equity related investments. Alcentra seeks to partner with business owners, management teams and financial sponsors by providing customized financing for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion and other growth initiatives.
Alcentra is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company under the Investment Company Act of 1940, as amended. In addition, for tax purposes, Alcentra has elected to be treated as a regulated investment company, or RIC, under Subchapter M of the Internal Revenue Code of 1986, as amended, or the Code.
FORWARD-LOOKING STATEMENTS
This press release may contain certain forward-looking statements. Any such statements, other than statements of historical fact, are based on management's current expectations, estimates, projections, beliefs and assumptions about the Company, its current and prospective portfolio investments, and its industry. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the Company's control, difficult to predict and could cause actual results to differ materially from those expected or forecasted in such forward-looking statements. Actual developments and results are likely to vary materially from these estimates and projections as a result of a number of factors, including those described from time to time in Alcentra' filings with the Securities and Exchange Commission. Such statements speak only as of the time when made, and Alcentra undertakes no obligation to update any such forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Alcentra Capital Corporation and Subsidiary |
|||||
Consolidated Statements of Assets and Liabilities |
|||||
As of |
As of | ||||
June 30, 2016 |
December 31, | ||||
(Unaudited) |
2015 | ||||
Assets |
|||||
Portfolio investments, at fair value |
|||||
Non-controlled, non-affiliated investments, at fair value (cost of $236,246,942 and $219,715,263, respectively) |
$ |
228,320,326 |
$ |
221,349,073 | |
Non-controlled, affiliated investments, at fair value (cost of $47,758,791 and $56,426,475, respectively) |
50,927,904 |
59,243,999 | |||
Controlled, affiliated investments, at fair value (cost of $14,788,295 and $27,289,995, respectively) |
14,390,754 |
15,748,539 | |||
Total of portfolio investments, at fair value (cost of $298,794,028 and $303,431,733, respectively) |
293,638,984 |
296,341,611 | |||
Cash |
5,038,752 |
4,866,972 | |||
Dividends and interest receivable |
1,517,925 |
2,607,205 | |||
Receivable for investments sold |
1,364,550 |
— | |||
Deferred financing costs |
1,801,484 |
2,183,881 | |||
Deferred tax asset |
927,632 |
1,382,408 | |||
Prepaid expenses and other assets |
249,005 |
113,730 | |||
Total Assets |
$ |
304,538,332 |
$ |
307,495,807 | |
Liabilities |
|||||
Credit facility payable |
$ |
51,685,846 |
$ |
63,504,738 | |
Notes payable (net of deferred note offering costs of $1,413,937 and $1,156,622, respectively) |
50,130,063 |
38,843,378 | |||
Other accrued expenses and liabilities |
278,021 |
271,801 | |||
Directors' fees payable |
72,500 |
37,025 | |||
Professional fees payable |
235,067 |
481,333 | |||
Interest and credit facility expense payable |
974,292 |
813,222 | |||
Management fee payable |
1,283,763 |
1,302,213 | |||
Income-based incentive fees payable |
2,023,682 |
1,081,797 | |||
Distributions payable |
4,586,816 |
4,595,700 | |||
Unearned structuring fee revenue |
1,354,846 |
689,577 | |||
Income tax liability |
825,900 |
842,812 | |||
Total Liabilities |
113,450,796 |
112,463,596 | |||
Commitments and Contingencies (Note 12) |
|||||
Net Assets |
|||||
Common stock, par value $0.001 per share (100,000,000 shares authorized, 13,490,636 and 13,516,766 shares issued and outstanding, respectively) |
13,491 |
13,517 | |||
Additional paid-in capital |
197,181,027 |
197,652,086 | |||
Accumulated net realized gain (loss) |
(4,440,768) |
2,791,590 | |||
Undistributed net investment income |
3,451,048 |
1,130,327 | |||
Net unrealized appreciation (depreciation) on investments, net of benefit/(provision) for taxes of $37,782 and $534,813 as of June 30, 2016 and December 31, 2015, respectively |
(5,117,262) |
(6,555,309) | |||
Total Net Assets |
191,087,536 |
195,032,211 | |||
Total Liabilities and Net Assets |
$ |
304,538,332 |
$ |
307,495,807 | |
Net Asset Value Per Share |
$ |
14.16 |
$ |
14.43 |
Alcentra Capital Corporation and Subsidiary |
|||||||
Consolidated Statement of Operations |
|||||||
Investment Income: |
For the three months ended June 30, 2016 (Unaudited) |
For the three months ended June 30, 2015 (Unaudited) |
For the six months ended June 30, 2016 (Unaudited) |
For the six months ended June 30, 2015 (Unaudited) | |||
From non-controlled, non-affiliated investments: |
|||||||
Interest income from portfolio investments |
$5,169,619 |
$4,286,969 |
$10,437,162 |
$8,444,528 | |||
Paid in-kind income from portfolio investments |
1,008,525 |
1,166,440 |
2,359,613 |
1,902,164 | |||
Other income from portfolio investments |
652,786 |
295,386 |
1,571,450 |
955,282 | |||
Dividend income from portfolio investments |
- |
302,874 |
- |
302,874 | |||
From non-controlled, affiliated investments: |
|||||||
Interest income from portfolio investments |
785,044 |
988,949 |
1,695,367 |
2,208,005 | |||
Paid in-kind income from portfolio investments |
634,025 |
631,046 |
1,485,164 |
1,242,545 | |||
Other income from portfolio investments |
1,845,055 |
20,527 |
1,950,937 |
48,885 | |||
From controlled, affiliated investments: |
|||||||
Interest income from portfolio investments |
382,888 |
582,229 |
764,635 |
1,158,209 | |||
Paid in-kind income from portfolio investments |
162,027 |
206,077 |
322,032 |
404,858 | |||
Other income from portfolio investments |
- |
27,043 |
- |
64,843 | |||
Total investment income |
10,639,969 |
8,507,540 |
20,586,360 |
16,732,193 | |||
Expenses: |
|||||||
Management fees |
1,283,763 |
1,219,963 |
2,572,799 |
2,367,968 | |||
Income-based incentive fees |
926,158 |
397,028 |
1,716,885 |
1,203,128 | |||
Capital gains incentive fees |
- |
434,217 |
- |
1,435,684 | |||
Professional fees |
372,535 |
170,549 |
726,537 |
359,935 | |||
Valuation services |
71,061 |
100,010 |
142,047 |
222,915 | |||
Interest and credit facility expense |
1,334,510 |
1,067,118 |
2,643,454 |
1,673,006 | |||
Amortization of deferred financing costs |
283,805 |
195,770 |
548,435 |
379,257 | |||
Directors' fees |
84,372 |
76,191 |
149,295 |
114,191 | |||
Insurance Expense |
65,771 |
68,006 |
132,381 |
137,541 | |||
Other expenses |
319,648 |
129,339 |
451,289 |
213,512 | |||
Total expenses |
4,741,623 |
3,858,191 |
9,083,122 |
8,107,137 | |||
Waiver of capital gains incentive fees |
- |
- |
- |
(1,001,467) | |||
Net expenses |
4,741,623 |
3,858,191 |
9,083,122 |
7,105,670 | |||
Net investment income |
5,898,346 |
4,649,349 |
11,503,238 |
9,626,523 | |||
Realized Gain (Loss) and Net Change in Unrealized Appreciation (Depreciation) From Portfolio Investments |
|||||||
Net realized gain (loss) on: |
|||||||
Non-controlled, non-affiliated investments |
23,802 |
(146,703) |
1,900,440 |
(146,449) | |||
Non-controlled, affiliated investments |
1,626,964 |
- |
2,021,697 |
- | |||
Controlled, affiliated investments |
- |
- |
(11,154,495) |
- | |||
Net realized gain (loss) from portfolio investments |
1,650,766 |
(146,703) |
(7,232,358) |
(146,449) | |||
Net change in unrealized appreciation (depreciation) on: |
|||||||
Non-controlled, non-affiliated investments |
(3,575,425) |
587,925 |
(9,560,426) |
(535,989) | |||
Non-controlled, affiliated investments |
(2,228,352) |
2,016,324 |
351,589 |
3,412,598 | |||
Controlled, affiliated investments |
(62,999) |
(286,458) |
11,143,915 |
(382,031) | |||
Net change in unrealized appreciation (depreciation) from portfolio investments |
(5,866,776) |
2,317,791 |
1,935,078 |
2,494,578 | |||
Benefit/(Provision) for taxes on unrealized gain on investments |
(287,167) |
(406,781) |
(497,031) |
(569,105) | |||
Net realized gain (loss) and net change in unrealized appreciation (depreciation) from portfolio investments |
(4,503,177) |
1,764,307 |
(5,794,311) |
1,779,024 | |||
Net Increase in Net Assets from Operations |
$1,395,169 |
$6,413,656 |
$5,708,927 |
$11,405,547 | |||
Basic and diluted: |
|||||||
Net Investment income per share |
$0.44 |
$0.34 |
$0.85 |
$0.71 | |||
Net increase in net assets resulting from operation per share |
$0.10 |
$0.47 |
$0.42 |
$0.84 | |||
Weighted Average Shares of Common Stock Outstanding |
13,500,429 |
13,516,766 |
13,507,973 |
13,516,766 | |||
Dividends Declared per common share |
$0.34 |
$0.34 |
$0.68 |
$0.68 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alcentra-capital-corporation-announces-second-quarter-2016-financial-results-and-announces-quarterly-dividend-of-034-per-share-300309661.html
SOURCE Alcentra Capital Corporation
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.